×
About 9,973 results

ALLMedicine™ Movement Disorders Center

Research & Reviews  3,135 results

Is essential tremor a degenerative or an electrical disorder? Electrical disorder.
https://doi.org/10.1016/bs.irn.2022.02.004
International Review of Neurobiology; Cho HJ

Jun 25th, 2022 - Essential tremor (ET) is one of the most common movement disorders, yet we do not have a complete understanding of its pathophysiology. From a phenomenology standpoint, ET is an isolated tremor syndrome of bilateral upper limb action tremor with o...

Neuroimaging in cerebellar ataxia in childhood: A review.
https://doi.org/10.1111/jon.13017
Journal of Neuroimaging : Official Journal of the America... Serrallach BL, Orman G et. al.

Jun 25th, 2022 - Ataxia is one of the most common pediatric movement disorders and can be caused by a large number of congenital and acquired diseases affecting the cerebellum or the vestibular or sensory system. It is mainly characterized by gait abnormalities, d...

Reduction of neuronal hyperexcitability with modulation of T-type calcium channel or SK...
https://doi.org/10.1016/bs.irn.2022.02.008
International Review of Neurobiology; Wagle Shukla A

Jun 25th, 2022 - Essential tremor is one of the most prevalent movement disorders. Propranolol and primidone are the first-line pharmacological therapies. They provide symptomatic control in less than 50% of patients. Topiramate, alprazolam, clonazepam, gabapentin...

Deep Brain Stimulation Surgery for Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT01581580

Jun 24th, 2022 - Objective: The objective of this protocol is to provide standard of care DBS surgery and to collect prospective physiology data related to DBS therapy and motor and cognitive function in people with medically refractory Parkinson s disease (PD), d...

Botulinum Toxin for the Treatment of Involuntary Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT00001208

Jun 24th, 2022 - The efficacy of botulinum toxin (BTX) has now been demonstrated for a variety of diseases associated with involuntary muscles spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the i...

see more →

Guidelines  3 results

Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disord...
https://doi.org/10.1002/mds.28465
Movement Disorders : Official Journal of the Movement Dis... Rusz J, Tykalova T et. al.

Dec 30th, 2020 - Most patients with movement disorders have speech impairments resulting from sensorimotor abnormalities that affect phonatory, articulatory, and prosodic speech subsystems. There is widespread cross-discipline use of speech recordings for diagnost...

ACR Appropriateness Criteria® Movement Disorders and Neurodegenerative Diseases.
https://doi.org/10.1016/j.jacr.2020.01.042
Journal of the American College of Radiology : JACR; , Harvey HB et. al.

May 7th, 2020 - Movement disorders and neurodegenerative diseases are a variety of conditions that involve progressive neuronal degeneration, injury, or death. Establishing the correct diagnosis of a movement disorder or neurodegenerative process can be difficult...

Dementia and movement disorders.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119123
AJNR. American Journal of Neuroradiology; Dormont D, Seidenwurm DJ et. al.

Jan 15th, 2008 - Dementia and movement disorders.|2008|Dormont D,Seidenwurm DJ, , ,|classification,complications,diagnosis,standards,classification,complications,diagnosis,

see more →

Drugs  13 results see all →

Clinicaltrials.gov  344 results

Deep Brain Stimulation Surgery for Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT01581580

Jun 24th, 2022 - Objective: The objective of this protocol is to provide standard of care DBS surgery and to collect prospective physiology data related to DBS therapy and motor and cognitive function in people with medically refractory Parkinson s disease (PD), d...

Botulinum Toxin for the Treatment of Involuntary Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT00001208

Jun 24th, 2022 - The efficacy of botulinum toxin (BTX) has now been demonstrated for a variety of diseases associated with involuntary muscles spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the i...

Phenotype/Genotype Correlations in Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT00018889

Jun 24th, 2022 - Objective: The primary objective of this study is to perform phenotypic and genotypic characterizations of patients and family members with a known or suspected diagnosis of a movement disorder and screen for eligibility to participate in other mo...

Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures
https://clinicaltrials.gov/ct2/show/NCT00500994

Jun 24th, 2022 - Objectives: The study investigates the neurobiological correlates of conversion disorder (CD). The primary objectives are to investigate in CD patients: The role of emotional valence in an implicit emotional processing task (COMPLETE) The frequenc...

Deep Brain Stimulation (DBS) Sedation
https://clinicaltrials.gov/ct2/show/NCT03283150

Jun 24th, 2022 - Deep brain stimulation (DBS) of different brain nuclei is evolving as an essential component of the treatment for multiple brain disorders. The subthalamic nucleus (STN) and globus pallidus have been used to treat advanced Parkinson's disease for ...

see more →

News  477 results

Assessing and Managing Functional Neurologic Disorders
https://www.medscape.com/viewarticle/973873

Jun 16th, 2022 - This transcript has been edited for clarity. Indu Subramanian, MD: It is so exciting to have you all join us again today. We're going to be talking about a really hot topic: functional neurologic disorders, and more specifically, functional moveme...

Which Antiseizure Drugs Are Associated With Movement Disorders?
https://www.medscape.com/viewarticle/967234

Jun 13th, 2022 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner, reporting on the American Epilepsy Society meeting. With me today is Dr Olga Taraschenko, director of the Comprehensive Epilepsy Program ...

The Latest in Movement Disorder Research
https://www.medscape.com/viewarticle/972408

May 19th, 2022 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Hello, and welcome to Medscape. Today we'll be discussing highlights in movement disorders from the recent American Academy of Neurology (AAN) annual meeting. I have the great pleas...

Skin Testing May Help Detect Movement Disorders
https://www.medscape.com/viewarticle/972853

May 18th, 2022 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm your host, Dr Andrew Wilner. Today, I am interviewing Dr Christopher Gibbons about his research presented at this year's American Academy of Neurology meet...

What Neurology Misses in Treating Women With Parkinson's
https://www.medscape.com/viewarticle/967760

Mar 24th, 2022 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Welcome to Medscape Neurology. I'm Dr Kathrin LaFaver, a neurologist and movement disorder specialist in Saratoga Springs, New York. I have the pleasure today of speaking with Dr In...

see more →

Patient Education  17 results see all →